Antibiotic Resistance: A mobile target
The global spread of antibiotic resistance could be due to a number of factors, and not just the overuse of antibiotics in agriculture and medicine as previously thought.
- Center for Environment Sciences and Humanities, Bard College, United States
- Center for Genomics and Systems Biology, New York University, United States
Antibiotic resistance – the ability of bacteria to survive even the strongest clinical treatments – continues to be a major public health concern around the world (Antimicrobial Resistance Collaborators, 2022). The overuse of antibiotics in medicine and agriculture is often thought to be the driving force behind the emergence and spread of bacteria that are resistant to antibiotics (Cohen, 1992; Levy and Marshall, 2004). Overuse can certainly explain the selection for bacteria with genes for antibiotic resistance in environments that are heavily impacted by human activity (Gaze et al., 2013; Kraemer et al., 2019), but it cannot explain the widespread distribution of genes for resistance to clinically relevant antibiotics well away from hospitals and farms. Indeed, such genes have even been found in environments as remote as the Arctic permafrost (D’Costa et al., 2011; Perron et al., 2015) and Antarctica (Hwengwere et al., 2022; Marcoleta et al., 2022).
Now, in eLife, Léa Pradier and Stéphanie Bedhomme of the University of Montpellier report the results of a study that sheds light on this matter (Pradier and Bedhomme, 2023). Focusing on resistance against aminoglycoside, a widely used family of antibiotics that includes streptomycin (Davies and Wright, 1997), the researchers conducted one of the largest surveys of antibiotic resistance genes to date. They analyzed more than 160,000 bacterial genomes collected from all over the globe, focusing on 27 clusters of genes that code for aminoglycoside-modifying enzymes (also known as AME genes). The bacteria were sampled between 1885–2019, although most were sampled recently, with the first example of a bacterium with an AME gene dating from 1905. In addition to the location and date of sampling, the study also considered the number of antibiotics consumed in each country, commercial trade routes, and human migration. Finally, the samples came from eleven different biomes, representing a range of environments where antibiotic resistance can be found: clinical environments (like hospitals), human habitats, domestic animals, farms, agrosystems, wild plants and animals, freshwater, seawater, sludge and waste, soil, and humans.
The researchers found that the prevalence of genes for aminoglycoside resistance increased between the 1940s and the 1980s, likely following an increase in the use of antibiotics after the discovery of streptomycin in 1943 (Schatz et al., 1944), and then remained at a prevalence of around 30%, despite an overall decrease in consumption. Crucially, they also discovered that around 40% of the resistance genes were potentially mobile, which means they can be easily exchanged between bacteria.
Pradier and Bedhomme also found that antibiotic-resistant bacteria are present in most biomes, and not just in hospitals and farms. Moreover, they found that the prevalence of aminoglycoside resistance genes varied more from biome to biome than it did with human geography or with the quantity of antibiotics used (Figure 1). This means that the antibiotic resistance found in humans in one country is more likely to be related to the antibiotic resistance found in humans in a distant country than it is to the antibiotic resistance found in the soil or animals nearby. Moreover, they also discovered that biomes such as soil and wastewater likely play a key role in spreading the genes for antibiotic resistance across different biomes.
Figure 1
Factors influencing the spread of resistance against aminoglycoside antibiotics.
Pradier and Bedhomme analyzed the variables that influence the prevalence of genes that code for aminoglycoside-modifying enzymes (AME genes) in a sample of 160,000 bacterial genomes collected from all over the globe. The samples were classified as belonging to one of eleven biomes (see main text). It was found that ecology (that is, which of the 11 biomes the sample was collected from) was the biggest influence, followed by human exchange (immigration and material import/export) and aminoglycoside consumption. This scatter plot for samples collected in Europe between 1997 and 2018, which is derived from Figure 5 of Pradier and Bedhomme, 2023, shows how the prevalence of 16 clusters of these genes depends on these three variables, with the thickness of each axis representing how influential that variable was overall (ecology, 80%; human exchange, 13%; aminoglycoside consumption, 7%; interactions between the variables are not included). The clusters of genes represented by circles code for N-acetyltransferases; triangles represent nucleotidyltransferases, and squares represent phosphotransferases.
These findings raise important questions about the mechanisms underlying the spread of antibiotic resistance. What factors promote the spread of antibiotic resistance in environments not impacted by human activities? Can we extrapolate these results from the aminoglycosides to all other classes of antibiotics? Is it possible that antibiotic resistance results from interactions with local microbial communities more than exposure to commercial antibiotics? Do the genes for antibiotic resistance spread in the pathogenic bacteria responsible for human and animal infections in the same way as they spread in non-pathogenic bacteria? Given the extent of the selective pressure exerted by human pollution, what limits the spread of antibiotic-resistance genes between biomes, especially given the large proportion of genes on mobile elements?
It may well be that consumption still has a paramount role when it comes to resistance to the antibiotics that are used to treat infection, especially in humans and clinical biomes. Nevertheless, it is clear that we need to pay more attention to the role of the environment when formulating plans to combat antibiotic resistance on a global scale.
References
-
Bacterial resistance to aminoglycoside antibioticsTrends in Microbiology 5:234–240.https://doi.org/10.1016/S0966-842X(97)01033-0
-
Influence of humans on evolution and mobilization of environmental antibiotic resistomeEmerging Infectious Diseases 19:e120871.https://doi.org/10.3201/eid1907.120871
-
Antibacterial resistance worldwide: causes, challenges and responsesNature Medicine 10:S122–S129.https://doi.org/10.1038/nm1145
-
The highly diverse Antarctic Peninsula soil microbiota as a source of novel resistance genesScience of the Total Environment 810:152003.https://doi.org/10.1016/j.scitotenv.2021.152003
-
Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteriaExperimental Biology and Medicine 55:66–69.https://doi.org/10.3181/00379727-55-14461
Article and author information
Author details
Carolina Oliveira de Santana
Publication history
- Version of Record published: March 8, 2023 (version 1)
Copyright
© 2023, Oliveira de Santana, Spealman et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 440
- Page views
-
- 30
- Downloads
-
- 0
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Antibiotic Resistance: A mobile target
eLife 12:e86697.
https://doi.org/10.7554/eLife.86697
Further reading
-
- Ecology
- Evolutionary Biology
Spider venoms are a complex concoction of enzymes, polyamines, inorganic salts, and disulfide-rich peptides (DRPs). Although DRPs are widely distributed and abundant, their bevolutionary origin has remained elusive. This knowledge gap stems from the extensive molecular divergence of DRPs and a lack of sequence and structural data from diverse lineages. By evaluating DRPs under a comprehensive phylogenetic, structural and evolutionary framework, we have not only identified 78 novel spider toxin superfamilies but also provided the first evidence for their common origin. We trace the origin of these toxin superfamilies to a primordial knot – which we name ‘Adi Shakti’, after the creator of the Universe according to Hindu mythology – 375 MYA in the common ancestor of Araneomorphae and Mygalomorphae. As the lineages under evaluation constitute nearly 60% of extant spiders, our findings provide fascinating insights into the early evolution and diversification of the spider venom arsenal. Reliance on a single molecular toxin scaffold by nearly all spiders is in complete contrast to most other venomous animals that have recruited into their venoms diverse toxins with independent origins. By comparatively evaluating the molecular evolutionary histories of araneomorph and mygalomorph spider venom toxins, we highlight their contrasting evolutionary diversification rates. Our results also suggest that venom deployment (e.g. prey capture or self-defense) influences evolutionary diversification of DRP toxin superfamilies.
-
- Ecology
- Evolutionary Biology
How the ecological process of community assembly interacts with intra-species diversity and evolutionary change is a longstanding question. Two contrasting hypotheses have been proposed: Diversity Begets Diversity (DBD), in which taxa tend to become more diverse in already diverse communities, and Ecological Controls (EC), in which higher community diversity impedes diversification. Previously, using 16S rRNA gene amplicon data across a range of microbiomes, we showed a generally positive relationship between taxa diversity and community diversity at higher taxonomic levels, consistent with the predictions of DBD (Madi et al., 2020). However, this positive 'diversity slope' plateaus at high levels of community diversity. Here we show that this general pattern holds at much finer genetic resolution, by analyzing intra-species strain and nucleotide variation in static and temporally sampled metagenomes from the human gut microbiome. Consistent with DBD, both intra-species polymorphism and strain number were positively correlated with community Shannon diversity. Shannon diversity is also predictive of increases in polymorphism over time scales up to ~4-6 months, after which the diversity slope flattens and becomes negative – consistent with DBD eventually giving way to EC. Finally, we show that higher community diversity predicts gene loss at a future time point. This observation is broadly consistent with the Black Queen Hypothesis, which posits that genes with functions provided by the community are less likely to be retained in a focal species' genome. Together, our results show that a mixture of DBD, EC, and Black Queen may operate simultaneously in the human gut microbiome, adding to a growing body of evidence that these eco-evolutionary processes are key drivers of biodiversity and ecosystem function.
